52-Week Range: $6.25-$16.92
Three-Month Average Volume: 1.27 million >>5 Stocks to Protect Your Portfolio Gains From a technical perspective, SSRI is ripping higher here right off some near-term support at $7 with decent upside volume. This move is quickly pushing shares of SSRI within range of triggering a near-term breakout trade. That trade will hit if SSRI manages to take out some near-term overhead resistance levels at $7.24 to $7.55 and then once it clears its 50-day at $8.05 with high volume. Traders should now look for long-biased trades in SSRI as long as it's trending above today's low of $6.99 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.27 million shares. If that breakout triggers soon, then SSRI will set up to re-test or possibly take out its next major overhead resistance levels at $9 to $10. Any high-volume move above $10 to $10.03 will then put $11 into range for shares of SSRI. pSivida pSivida ( PSDV) develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. This stock is trading up 5.3% to $3.33 in recent trading. Today's Range: $3.15-$3.34
52-Week Range: $1.17-$3.50
Three-Month Average Volume: 104,658 Shares of PSDV are ripping higher today after the company said it signed a funded technology evaluation agreement with a leading global pharmaceutical company. >>5 Trading Setups With Upside This Week From a technical perspective, PSDV is trending higher here with above-average volume. This stock has been uptrending strong for the last five months, with shares soaring higher from its low of $1.17 to its intraday high of $3.34. During that uptrend, shares of PSDV have been consistently making higher lows and higher highs, which is bullish technical price action. That move is quickly pushing shares of PSDV within range of triggering a major breakout trade. That trade will hit if PSDV manages to take out some past overhead resistance at $3.50 with high volume.